Skip to main content

Future cancer


The Future Cancer inquiry will explore innovations in cancer diagnosis and treatment.

It will look at the innovations with the greatest potential to transform cancer diagnosis and treatment for patients in the short, medium and long term, and it will examine how innovations in diagnosing and treating cancer can best be transitioned into frontline clinical settings. It will also explore international examples of best practice.

Types of innovations that could be examined by the inquiry range from medicines and vaccines to artificial intelligence. 

This inquiry builds on the Committee's recent work on cancer services, including its report in April 2022, which was focused largely on current provision of cancer services and the impact of the covid-19 pandemic.

Please first read the important information on this webpage and the terms of reference on the portal page. Your submission should be no more than 3,000 words.  



This inquiry is no longer accepting evidence

The deadline for submissions was Wednesday 26 April 2023.

Upcoming events

View all events

No upcoming events scheduled

Past events

Monday 29 January 2024
4:00pm Private
4:30pm Public
Future cancer - Oral evidence 29 January 2024
  • Professor Peter Johnson (National Clinical Director for Cancer at NHS England)
  • Dame Cally Palmer (National Cancer Director at NHS England)
  • Rt Hon Andrew Stephenson (Minister of State (Minister for Health and Secondary Care) at Department of Health and Social Care)
The Thatcher Room, Portcullis House
Tuesday 9 January 2024
9:30am Private
10:00am Public
Future cancer - Oral evidence 9 January 2024
  • Professor David Baldwin (Consultant Respiratory Physician and Honorary Professor of Medicine at School of Medicine (University of Nottingham))
  • Professor David Chang (Co-Lead of Precision-Panc, and Chair of Surgical Oncology at University of Glasgow)
  • Dr Paul Mullholland (Honorary Associate Professor and Consultant in medical oncology at University College London and University College London Hospitals)
  • Dr Julie Gralow (Executive Vice President and Chief Medical Officer at American Society of Clinical Oncology)
  • Professor Mark Lawler (Board Member (European Cancer Organisation), and Associate Pro-Vice-Chancellor and Professor of Digital Health at Queen's Univeristy Belfast)
Room 6, Palace of Westminster
Tuesday 28 November 2023
9:30am Private
10:00am Public
Future cancer - Oral evidence 28 November 2023
  • Professor Paul Dalby (Co-Director of the Future Targeted Healthcare Manufacturing Hub; Deputy Head of the Department of Biochemical Engineering at University College London)
  • James Hargrave (Vice-Chair at Keep Up With Cancer)
  • Tony Hickson (Chief Business Officer at Cancer Research Horizons and Cancer Research UK)
  • Julian Beach (Interim Executive Director, Healthcare Quality and Access at Medicines and Healthcare products Regulatory Agency (MHRA))
  • Sarah Byron (Programme Director of Devices, Diagnostics and Digital at National Institute for Health and Care Excellence (NICE))
Room 5, Palace of Westminster
Thursday 14 September 2023
9:00am Private
9:30am Public
Future cancer - Oral evidence 14 September 2023
  • Professor Sir John Bell (Regius Professor of Medicine at Oxford University)
  • Dr Robin Buckle (Chief Science Officer at Medical Research Council)
  • Dr Susan Galbraith (Executive Vice President of Oncology Research & Development at AstraZeneca)
  • Professor Kevin Harrington (Head of the Division of Radiotherapy and Imaging at Institute of Cancer Research)
The Grimond Room, Portcullis House

Contact us

We can't usually help you with an individual problem or a specific complaint.

  • Email:
  • Phone: (general enquiries) 020 7219 6182 | 020 7219 6832 (media enquiries)
  • Address: Health and Social Care Committee, House of Commons, London, SW1A 0AA